Dr. Jennifer Sara Landy, MD

Dr. Landy practices at Eye Associates of Pinellas in Pinellas Park, Florida.

Dr. Landy's NPI, 1386609329, was assigned on April 20, 2006. Dr. Landy graduated from University of Maryland School of Medicine - Baltimore in 1999. Dr. Landy holds Florida license ME89152.

Dr. Landy's primary practice is Eye Associates of Pinellas, at 9375 66th N St, Pinellas Park, FL 33782 in Pinellas County. The practice phone is (727) 541-4469.

Dr. Landy's primary practice is Eye Associates of Pinellas in Pinellas Park, Florida. Dmand AI also links Dr. Landy to 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Landy practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Landy's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Landy is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Landy's licenses on file in 4 states: Florida, New Jersey, New York and Pennsylvania.

Dmand AI lists dry eye, eye infection or inflammation, eyelid inflammation, vision problems and visual impairment and blindness among the conditions Dr. Landy treats.

CMS data shows 4,356 Medicare services from Dr. Landy across 12 procedure codes in 2024, for 227 Medicare patients. Medicare paid $114,831 for them.

CMS counts 227 Medicare patients who saw Dr. Landy in 2024. The largest group is 65 to 74, with 95 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Landy's median patient age at 72, with 64% women.

In 2024, Dr. Landy wrote 639 Medicare Part D claims for 295 patients. 59% of them were for generic drugs. CMS names the drug for 544 of them, across 15 drugs with 11 or more claims each, at $788,169 in total drug cost. In 2023, CMS named 395 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Landy for performance year 2024, reported as part of a group. Dr. Landy accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Landy. The most frequent topics are Health Status Indicators, Vision Disorders and Visual Acuity.

CMS Open Payments shows 151 general payments to Dr. Landy from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 70% of the total. Horizon Pharma plc paid the most, $4,754.

Dr. Landy graduated from University of Maryland School of Medicine - Baltimore in 1999.

Dr. Landy is in network with 22 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 15. Check the plan with the practice before a visit.